It then presents a few representative cases of pain management in older adults. The goal of this review is to provide relevant information that can be used to manage acute postoperative pain in ...

BERWYN, Pa. - Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX), a micro-cap pharmaceutical company with a market capitalization of $1.43 million focused on non-addictive pain management treatments, has ...

When necessary, naloxone (an opioid antagonist) can be administered. Naloxone can cause opioid withdrawal, sudden severe pain, hypertension and pulmonary edema. The manufacturer of naloxone ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

The administrative complaint against Dr. Oliver Simmons was filed Jan. 3 and concerns a 2023 surgery while Simmons was at New Life Plastic Surgery, 8400 SW Eighth St. At one point in 2023, liposuction ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Suzetrigine is under clinical development by Vertex Pharmaceuticals and currently in Pre-Registration for Post-Operative Pain. According to GlobalData, Pre-Registration drugs for Post-Operative Pain ...

HT-6184 is under clinical development by Halia Therapeutics and currently in Phase II for Post-Operative Pain. According to GlobalData, Phase II drugs for Post-Operative Pain have a 53% phase ...

Take Back Your Life™ with ISP Health. Dr. John S. Michels and his team are here to help you reclaim your life from pain. The office staff of eight compassionate team members is led by Dr.

Purpose This retrospective cohort study aimed to investigate the association between chronic postsurgical pain (CPSP) and the risk of postoperative depression in patients undergoing major surgery.

“It offers a safer option for managing moderate-to-severe acute pain, reducing reliance on opioids,” he said. “It offers rapid relief and can be integrated into postoperative pain protocols ...